Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Raw Materials (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Raw Materials for 3 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Raw Materials changed N/A to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.4 million for FY2025, N/A changed from the prior year.
  • Raw Materials for Q4 2025 was $1.4 million at Adagio Medical Holdings, up from $1.4 million in the prior quarter.
  • The five-year high for Raw Materials was $2.5 million in Q3 2024, with the low at $1.4 million in Q3 2025.
  • Average Raw Materials over 3 years is $1.8 million, with a median of $1.6 million recorded in 2025.
  • Peak annual rise in Raw Materials hit 45.15% in 2025, while the deepest fall reached 45.15% in 2025.
  • Over 3 years, Raw Materials stood at $2.2 million in 2023, then increased by 15.2% to $2.5 million in 2024, then plummeted by 44.13% to $1.4 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $1.4 million, $1.4 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.